Lifevantage Corporation Common Stock (Delaware) earnings per share and revenue
On Feb 04, 2026, LFVN reported earnings of 0.15 USD per share (EPS) for Q2 26, missing the estimate of 0.15 USD, resulting in a -1.96% surprise. Revenue reached 48.93 million, compared to an expected 55.47 million, with a -11.80% difference. The market reacted with a -16.76% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 5 analysts forecast an EPS of 0.15 USD, with revenue projected to reach 48.72 million USD, implying an increase of 0.00% EPS, and decrease of -0.43% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Staar Surgical Co
Report Date
Mar 03, 2026 For Q4 25
Estimate
$0.05
Actual
-$0.37
Surprise
-734.65%
The Cooper Companies, Inc. Common Stock
Report Date
Mar 05, 2026 For Q1 26
Estimate
$1.04
Actual
$1.10
Surprise
+5.74%
FAQ
What were Lifevantage Corporation Common Stock (Delaware)'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Lifevantage Corporation Common Stock (Delaware) reported EPS of $0.15, missing estimates by -1.96%, and revenue of $48.93M, -11.8% below expectations.
How did the market react to Lifevantage Corporation Common Stock (Delaware)'s Q2 2026 earnings?
The stock price moved down -16.76%, changed from $5.55 before the earnings release to $4.62 the day after.
When is Lifevantage Corporation Common Stock (Delaware) expected to report next?
The next earning report is scheduled for May 04, 2026.
What are the forecasts for Lifevantage Corporation Common Stock (Delaware)'s next earnings report?
Based on 5
analysts, Lifevantage Corporation Common Stock (Delaware) is expected to report EPS of $0.15 and revenue of $48.72M for Q3 2026.